Stopping progression to phaceous gout: When and how to use urate- lowering therapy

Postgraduate Medicine

Volumn 104, Issue 6, 1998, Pages 117-127

  McDonald, Elizabeth ^a   Marino, Catherine ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMPICILLIN; ANTICOAGULANT AGENT; ANTIMETABOLITE; AZATHIOPRINE; BENURYL; COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOSPORIN; CYCLOSPORIN A; DIURETIC AGENT; ETHANOLAMINE DERIVATIVE; INDOCHRON; MERCAPTOPURINE; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OXIPURINOL; PREDNISONE; PROBENECID; PURINE DERIVATIVE; PURINOL; PYRAZINAMIDE; SALICYLIC ACID; SULFINPYRAZONE; THIAZIDE DIURETIC AGENT; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; URIC ACID DERIVATIVE; XANTHINE OXIDASE INHIBITOR; ANTIGOUT AGENT; URICOSURIC AGENT;

ARTHRITIS; ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG ERUPTION; EOSINOPHILIA; GOUT; HUMAN; HYPERURICEMIA; IMMUNE COMPLEX NEPHRITIS; INTRAARTICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LESCH NYHAN SYNDROME; LIVER TOXICITY; ORAL DRUG ADMINISTRATION; POLYCYTHEMIA VERA; URIC ACID BLOOD LEVEL; VASCULITIS; FEMALE; MALE;

ADRENAL CORTEX HORMONES; ALLOPURINOL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, GOUTY; COLCHICINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GOUT; GOUT SUPPRESSANTS; HUMANS; MALE; URICOSURIC AGENTS;

EID: 0032410945     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.12.394     Document Type: Article

References (15)

1. Kelley WN, Wortmann RL. Gout and hyperuricemia. In: Kelley WN, Ruddy S, Harris ED Jr, et al, eds. Textbook of rheumatology. 5th ed. Philadelphia: Saunders, 1997:1313-51
2. Yu TF. Diversity of clinical features in gouty arthritis. Semin Arthritis Rheum 1984;13(4):360-8
3. Puig JG, Michan AD, Jimenez ML, et al. Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 1991;151(4):726-32
4. Lally EV, Ho G Jr, Kaplan SR. The clinical spectrum of gouty arthritis in women. Arch Intern Med 1986; 146(11):2221-5
5. Gerster JC, Landry M, Duvoisin B, et al. Computed tomography of the knee joint as an indicator of intraarticular tophi in gout. Arthritis Rheum 1996;39(8):1406-9
6. Popp JD, Bidgood WD Jr, Edwards NL. Magnetic resonance imaging of tophaceous gout in the hands and wrists. Semin Arthritis Rheum 1996;25(4):282-9
7. McCarty DJ. Gout without hyperuricemia. JAMA 1994;271(4):302-3
8. McCarthy GM, Barthelemy CR, Veum JA, et al. Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout. Arthritis Rheum 1991; 34(12):1489-94
9. Zonana-Nacach A, Alarcon GS, Daniel WW. Rheumatoid arthritis preceding the onset of polyarticular tophaceous gout. (Letter) Ann Rheum Dis 1996; 55(7):489-90
10. Uri DS, Martel W. Radiologic manifestations of the crystal-related arthropathies. Semin Roentgenol 1996; 31(3):229-38
11. Wallace SL, Singer JZ. Therapy in gout. Rheum Dis Clin North Am 1988; 14(2):441-57
12. Emmerson BT. The management of gout. N Engl J Med 1996;334(7):445-51
13. Schumacher HR, Alvarez MJ. Clues to common crystal induced arthropathies. IM 1993 Dec;35-47
14. Ferraz MB, O'Brien B. A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis. J Rheumatol 1995;22(5):908-14
15. Rosenthal AK, Ryan LM. Treatment of refractory crystal-associated arthritis. Rheum Dis Clin North Am 1995; 21(1):151-6